Filing Details

Accession Number:
0001104659-24-117794
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-13 16:58:51
Reporting Period:
2024-11-11
Accepted Time:
2024-11-13 16:58:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1657312 Verona Pharma Plc VRNA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1627642 David Zaccardelli 3 More London Riverside
London X0 SE1 2RE
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2024-11-11 2,400 $5.00 15,202,352 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
  2. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted on March 8, 2024.
  3. Consists of (i) 3,000,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 375,000 ADSs); and (ii) 12,202,352 Ordinary Shares underlying 1,525,294 ADSs.